Write your message
Volume 4, Issue 1 (Winter 2019)                   J Obstet Gynecol Cancer Res 2019, 4(1): 5-11 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aminimoghaddam S, Abolghasem N. A Review of Management of Perimenopausal Hot Flashes. J Obstet Gynecol Cancer Res 2019; 4 (1) :5-11
URL: http://jogcr.com/article-1-181-en.html
1- Gynecologist Oncologist, Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran , aminimoghaddam.s@iums.ac.ir
2- Resident of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (1965 Views)

Vasomotor symptoms, also known as hot flashes, can be defined as a sensation of heat, intense sweating, and flushing, which are experienced episodically by many perimenopausal women. This sensation usually affects the face, neck, and chest. It is estimated that about 75% to 80% of women would suffer from hot flashes at some point during their perimenopausal years. A decline in oestrogen levels during menopause seems to be responsible for the appearance of hot flashes. This decline increases norepinephrine levels, leading to an up-regulation of serotonin receptors in the hypothalamus, which are involved in temperature regulation. The outcome of the activation of this norepinephrine serotonin pathway is believed to be the narrower thermoregulation zone, which in turn results in a greater risk of crossing the upper and lower thresholds of the thermoregulatory zone. Thus, it causes sweats and chills in this group of women. The most known effective treatment of hot flashes is hormone replacement therapy (HRT); however, in recent years, other non-hormonal options have become available for those women who cannot or do not want to take HRT.

Full-Text [PDF 273 kb]   (1171 Downloads) |   |   Full-Text (HTML)  (2099 Views)  
Systematic Review: Review | Subject: Gynecology Oncology
Received: 2018/09/5 | Accepted: 2018/12/6 | Published: 2019/03/1

References
1. Deecher D, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Archives of women's mental health. 2007;10(6):247-57. [DOI:10.1007/s00737-007-0209-5] [PMID]
2. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL, editors. Pathophysiology and treatment of hot flashes. Mayo Clinic Proceedings; 2002: Elsevier. [DOI:10.4065/77.11.1207] [PMID]
3. Freedman RR. Hot flashes: behavioral treatments, mechanisms, and relation to sleep. The American journal of medicine. 2005;118(12):124-30. https://doi.org/10.1016/j.amjmed.2005.10.022 [DOI:10.1016/j.amjmed.2005.09.046] [PMID]
4. Dalal S, Zhukovsky DS. Pathophysiology and management of hot flashes. The journal of supportive oncology. 2006;4(7):315-20, 25.
5. Minarik PA. Sleep disturbance in midlife women. Journal of Obstetric, Gynecologic & Neonatal Nursing. 2009;38(3):333-43. [DOI:10.1111/j.1552-6909.2009.01031.x] [PMID]
6. Bachmann GA, Schaefers M, Uddin A, Utian WH. Lowest effective transdermal 17β-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial. Obstetrics & Gynecology. 2007;110(4):771-9. [DOI:10.1097/01.AOG.0000284450.51264.31] [PMID]
7. Investigators WGftWsHI. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama. 2002;288(3):321-33. [DOI:10.1001/jama.288.3.321] [PMID]
8. LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. Jama. 2011;305(13):1305-14. [DOI:10.1001/jama.2011.382] [PMID] [PMCID]
9. Jungheim ES, Colditz GA. Short-term use of unopposed estrogen: a balance of inferred risks and benefits. Jama. 2011;305(13):1354-5. [DOI:10.1001/jama.2011.405] [PMID]
10. Morrow PKH, Mattair DN, Hortobagyi GN. Hot flashes: a review of pathophysiology and treatment modalities. The oncologist. 2011: theoncologist. 2011-0174. [DOI:10.1634/theoncologist.2011-0174] [PMID] [PMCID]
11. Orleans RJ, Li L, Kim M-J, Guo J, Sobhan M, Soule L, et al. FDA approval of paroxetine for menopausal hot flushes. New England Journal of Medicine. 2014;370(19):1777-9. [DOI:10.1056/NEJMp1402080] [PMID]
12. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. Bmj. 2005;330(7488):385. [DOI:10.1136/bmj.330.7488.385] [PMID] [PMCID]
13. Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. Journal of the National Cancer Institute. 2003;95(23):1758-64. [DOI:10.1093/jnci/djg108] [PMID]
14. Johnson ED, Carroll DG. Venlafaxine and desvenlafaxine in the management of menopausal hot flashes. Pharmacy Practice. 2011;9(3):117.
15. Aminimoghaddam S, Yarandi F, Nejadsalami F, Taftachi F. Human chorionic gonadotrophin as an indicator of persistent gestational trophoblastic neoplasia. Medical journal of the Islamic Republic of Iran. 2014; 28:44.
16. Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. The Lancet. 2005;366(9488):818-24. [DOI:10.1016/S0140-6736(05)67215-7]
17. Reddy SY, Warner H, Guttuso T, Messing S, DiGrazio W, Thornburg L, et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstetrics & Gynecology. 2006;108(1):41-8. [DOI:10.1097/01.AOG.0000222383.43913.ed] [PMID]
18. Aranda C, Costa M, Meireles P, Natel E, Simplicio A, Ostaszewski A, et al., editors. Dress syndrome, gabapentin (GB) and autografts. World Allergy Organization Journal; 2015: Springer. [DOI:10.1186/1939-4551-8-S1-A166] [PMCID]
19. Sharifzadeh F, Aminimoghaddam S, Kashanian M, Fazaeli M, Sheikhansari N. A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia. Gynecological Endocrinology. 2017;33(2):152-5. [DOI:10.1080/09513590.2016.1223285] [PMID]
20. Aminimoghaddam S, Nezhadisalami F, Anjidani S, Barzin Tond S. Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/etoposide and cisplatin) regimen in gestational trophoblastic neoplasia. Medical Journal of the Islamic Republic of Iran (MJIRI). 2018;32(1):209-13. [DOI:10.14196/mjiri.32.36] [PMID] [PMCID]
21. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. American Journal of Obstetrics & Gynecology. 1987;156(3):561-5. [DOI:10.1016/0002-9378(87)90050-0]
22. Nelson MR, Reid CM, Krum H, Ryan P, Wing LM, McNeil JJ. Short-term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in the second Australian National Blood Pressure Study (ANBP2). American journal of hypertension. 2003;16(1):39-45. [DOI:10.1016/S0895-7061(02)03143-6]
23. Mohammad-Alizadeh-Charandabi S, Shahnazi M, Nahaee J, Bayatipayan S. Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial. Chinese medicine. 2013;8(1):20. [DOI:10.1186/1749-8546-8-20] [PMID] [PMCID]
24. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. Journal of Clinical Oncology. 2000;18(5):1068. [DOI:10.1200/JCO.2000.18.5.1068] [PMID]
25. Poonyachoti S, Deachapunya C. Modulatory effects of phytoestrogens on the expression of Fas ligand and the release of cytochrome C in normal and cancerous endometrial cells. Journal of the Medical Association of Thailand= Chotmaihet thangphaet. 2012;95: S105-12.
26. Ziaei S, Kazemnejad A, Zareai M. The effect of vitamin E on hot flashes in menopausal women. Gynecologic and obstetric investigation. 2007;64(4):204-7. [DOI:10.1159/000106491] [PMID]
27. Ghaoomi M, Aminimoghaddam S, Safari H, Mahmoudzadeh A. Awareness and practice of cervical cancer and Pap smear testing in a teaching hospital in Tehran. Tehran University Medical Journal TUMS Publications. 2016;74(3):183-9.
28. Nedstrand E, Wijma K, Wyon Y, Hammar M. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Maturitas. 2005;51(2):154-62. [DOI:10.1016/j.maturitas.2004.05.017] [PMID]
29. Wolman I. Berek and Novak's gynecology 16th edition. Springer; 2020.
30. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams obstetrics, 25e: Mcgraw-hill; 2018.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.